UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ARVN — Arvinas, Inc.
CIK 861177
NEW YORK, NY
Position in ARVN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$913,815
-$262,507 QoQ
Shares Held
109,966
-0.9% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 48%
Shared 0%
None 52%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. ARVN ranks #120 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in ARVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $913,815 | 109,966 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,176,322 | 110,974 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,474,444 | 124,321 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,065,951 | 125,112 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,344,013 | 182,611 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,338,527 | 902,925 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $8,310,784 | 433,531 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,602,816 | 430,484 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,477,901 | 431,176 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,028,792 | 194,496 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,574,513 | 232,617 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,156,263 | 160,706 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,010,265 | 161,574 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,414,198 | 161,574 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,736,637 | 167,689 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,056,867 | 158,617 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,152,649 | 51,144 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,083,482 | 45,817 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,562,573 | 43,372 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,485,251 | 42,410 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,388,770 | 44,010 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,168,939 | 32,813 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,037,300 | 23,988 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $4,443,566 | 188,207 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $15,421,120 | 459,783 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $12,387,009 | 307,370 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||